EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Buprenorphine: A guide for ED providers

Buprenorphine: A guide for ED providers

by Max Zworth, Rebecca Seliga | Mar 9, 2023 | Addictions, Critical Care, Featured, Grand Round Summaries, Resuscitation, Toxicology

The opioid epidemic is not new to ED providers, but many will be shocked to learn about the true extent of the harm caused by opioids in Canada.  In the first half of 2022, there were 3556 recorded deaths due to opioid toxicity in Canada. This amounts to 19 deaths...
Last Gag with Mary Jane: Cannabinoid Hyperemesis Syndrome (CHS)

Last Gag with Mary Jane: Cannabinoid Hyperemesis Syndrome (CHS)

by Julie Ingratta, Alex Coutin | Jul 14, 2022 | Addictions, emergency, Featured, Gastroenterology, Grand Round Summaries, Main page, Public health, Toxicology

With legalization, and increased ease of access to marijuana, there is increased focus on the diagnosis of Cannabinoid Hyperemesis Syndrome, with broader media attention and thus patient awareness to this entity.  History: Cannabis (Cannabis sativa spp.) has been...
Intravenous Lipid Emulsion: The New Fad Diet

Intravenous Lipid Emulsion: The New Fad Diet

by Kevin Durr, Sam Wilson, Josee Malette | Jan 20, 2022 | Featured, Grand Round Summaries, Resident Insights, Resuscitation, Toxicology

Much uncertainty still exists surrounding intravenous lipid emulsion (ILE) therapy. The precise mechanism of action remains unknown, no definitive consensus exists regarding its clinical indications, and there are no high quality studies evaluating its potential...
Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial

Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial

by Elyssia Adamo, Hans Rosenberg | Dec 30, 2021 | Full Article, Journal Club, mental health, psychiatry, Toxicology

Methodology: 3.5/5 Usefulness: 3.5/5 Barbic D, et al. Ann Emerg Med. 2021 Aug 2:S0196-0644(21)00433-9. Question and Methods: Randomized, single center, blinded clinical trial comparing the rapidity of onset, level of sedation and adverse effect profile of Ketamine...
Back to Black: A Review of Activated Charcoal

Back to Black: A Review of Activated Charcoal

by Alexandra Hamelin, Alie Wudwud | Jul 15, 2021 | Critical Care, Featured, Grand Round Summaries, Resuscitation, Social Media, Toxicology

In this blog post, Dr. Alexandra Hamelin weighs in on many of the controversies surrounding activated charcoal (AC), and provides a practical approach for its use in overdose patients in the emergency department. Specifically: The dosing of AC The time window...
Early Bird Catches The Burn: Hydrofluoric Acid Treatment

Early Bird Catches The Burn: Hydrofluoric Acid Treatment

by Nicole Mathies, Chirag Bhat, Alexandra Hamelin, Josee Malette | Jan 14, 2021 | Featured, Occupational Health, Toxicology

Case Presentation A 30-year-old male presents to urgent care with a complaint of excruciating pain in his left hand. He is a gardener, and earlier that day had been mixing a solution of pesticides. He had been wearing gardening gloves to open the solutions, including...
Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

by Hans Rosenberg | Oct 5, 2020 | Addictions, Journal Club, Toxicology

Methodology: 3/5 Usefulness: 2/5 Anton RF, et al. JAMA Intern Med. 2020 Mar 9;180(5):1-9.  Question and Methods: Blinded randomized control trial comparing gabapentin to placebo in reducing the number of heavy drinking days in alcohol use disorder treatment. Findings:...
Distilling it Down Part I: Alcohol Withdrawal in the ED

Distilling it Down Part I: Alcohol Withdrawal in the ED

by Michael Wong, Alex Coutin | Aug 13, 2020 | Critical Care, Featured, psychiatry, Toxicology

In Ontario, Canada, alcohol-related ED visits have increased 4.4x faster than the overall increase in visits from 2003-2016, and was responsible for more admissions than heart attacks in 2016. In part 1 of this 2-part series, we will discuss tips for the diagnosis and...
Let’s talk about some drugs

Let’s talk about some drugs

by Shahbaz Syed | Jun 11, 2020 | Featured, Grand Round Summaries, Resuscitation, Toxicology

Here, we seek to explore some controversial, poorly known, or irrelevant drugs in medicine in a menagerie of drug cocktails. 1. What drugs best treat SVT? A patient presents with the following rhythm strip, they’re totally stable, on no medications and with no...
E-cigarette and Vaping Associated Lung Injury (EVALI)

E-cigarette and Vaping Associated Lung Injury (EVALI)

by Harrison Carmichael, Pascale King | Nov 28, 2019 | Featured, Grand Round Summaries, Respirology, Toxicology

You may have seen the headlines; E-cigarette and Vaping Associated Lung Injury (EVALI) represent a new disease process that is potentially life-threatening. Emergency Physicians will inevitably be exposed to EVALI as front line health care providers. Here, we will...
« Older Entries
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.